Former UFC heavyweight champion has been notified by the US Anti-Doping Agency of a failed out-of-competition medication measure on 28 June
Brock Lesnar has been flagged for a potential anti-doping abuse in the wake of his unanimous-decision victory over Mark Hunt at UFC 200.
The UFC problem a declaration on Friday afternoon saying Lesnar and the promotion had been notified by the US Anti-Doping Agency of a failed out-of-competition stimulant experiment on 28 June. Usada did not disclose the name of the substance Lesnar tested positive for in keeping with organizational policy.
A decorated amateur wrestler, Lesnar signed with the UFC in 2007 and defeated Randy Couture for the promotions heavyweight championship the subsequent year. He did two successful designation protections before losing to Cain Velasquez by first-round TKO, then announced his retirement from mixed martial art after a stoppage loss to Alistair Overeem in 2011.
Saturdays fight with Hunt was Lesnars firstly in five years old. The 38 -year-old South Dakota native gave a record $2.5 m handbag for the three-round degrees triumph, with all three judges siding down scores of 29 -2 8.
The UFC said Usada, the independent administrator of the organisation anti-doping plan, received the testing the outcomes of the 28 June sample collect on Thursday evening after it was measured at the Wada-accredited UCLA Olympic Analytical Laboratory.
The original headline bout of Saturdays card a light-colored heavyweight deed campaign between Jon Jones and Daniel Cormier was scrapped when Jones tested positive for a censored essence. Cormier instead engaged Anderson Silva on the undercard, while the status of women bantamweight championship campaign between Amanda Nunes and Miesha Tate was heightened to the main event.
The UFC 200 main event had to be scrapped three days before the affair because Jon Jones is positive for censored essences in an out-of-competition exam. Daniel Cormier engaged Anderson Silva instead. Jones is also awaiting the USADA adjudication process.
Read more: www.theguardian.com